ChloraPrep (CareFusion Corp.) for skin antisepsis
Record ID 32011000794
English
Authors' objectives:
Intravascular catheters and surgical procedures that disrupt the skin can allow bacteria to enter the body, causing potentially severe infections. Each year in the United States, approximately 250,000 catheter-related bloodstream infections occur, often as an unintended consequence of central venous catheterization. Postsurgical and catheter-related infections can be deadly. Contamination of blood cultures with bacteria can also occur, delaying accurate diagnosis until uncontaminated cultures are obtained. To prevent intravascular catheter-related infections, the Centers for Disease Control and Prevention recommend the use of 2% chlorhexidine.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=9308
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- 2-Propanol
- Antisepsis
- Chlorhexidine
- Skin
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.